Form 8-K - Current report:
SEC Accession No. 0000950170-24-001073
Filing Date
2024-01-03
Accepted
2024-01-03 17:05:24
Documents
13
Period of Report
2024-01-02
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K cmra-20240102.htm   iXBRL 8-K 68750
  Complete submission text file 0000950170-24-001073.txt   234806

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cmra-20240102.xsd EX-101.SCH 3387
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cmra-20240102_lab.xml EX-101.LAB 23700
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cmra-20240102_def.xml EX-101.DEF 14681
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cmra-20240102_pre.xml EX-101.PRE 14886
7 EXTRACTED XBRL INSTANCE DOCUMENT cmra-20240102_htm.xml XML 6427
Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 (617)871-2101
Comera Life Sciences Holdings, Inc. (Filer) CIK: 0001907685 (see all company filings)

EIN.: 874706968 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41403 | Film No.: 24507945
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)